Sign in

CIK 0001710072 · Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821725586
Phone
720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 10-K Report Annual Report
  5. 8-K Event Results of operations
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Planned sale General Counsel sold 29,835 shares at an average $20.00 ($596,805)
  9. 4 Planned sale Chief Business Officer sold 10,000 shares at an average $20.03 ($200,258)
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 4 Planned sale Chief Financial Officer sold 90,000 shares at $15.78 ($1,419,759)
  18. 4 Open-market buy Director bought 454,545 shares at $11.00 ($4,999,995)
  19. 4 Open-market buy Director bought 454,545 shares at $11.00 ($4,999,995)
  20. SC 13D/A Stake Beneficial Ownership Report

Page 11 of 22 · 423 filings